Stem bromelain clinical trials
How each study uses stem bromelain is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the stem bromelain studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2021 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2025 | 1 |
Who runs them
Industry 6 · Other 0
MediWound Ltd (6)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test stem bromelain, phase 3 first.
- Dec 2026A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)Phase 3 · MediWound Ltd
Studies
Open first, then newest update. How each study uses stem bromelain is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)Not yet recruitingPhase 2MediWound LtdNCT06690177Written as EscharEx (EX-03)
- A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)RecruitingPhase 3MediWound LtdNCT06568627Written as EscharEx (EX-03)
- A Study to Evaluate the Safety and the Efficacy of EscharEx (EX-02 Formulation) in Debridement of Venous Leg UlcersCompletedPhase 2MediWound LtdNCT03588130Written as EscharEx (5% EX-02 formulation)
- A Study to Evaluate the Clinical Performance, Safety and Pharmacology Effect of EscharEx in Patients With Lower Leg UlcersCompletedPhase 2MediWound LtdNCT04817228Written as EscharEx (EX-02 formulation)
- A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell CarcinomaStatus unknownPhase 1/2MediWound LtdNCT05157763Written as EscharEx 5% (EX-02 formulation)
- Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal WoundsCompletedPhase 2MediWound LtdNCT02020746Written as EscharEx
Codes
What other systems call stem bromelain · ClinicalTrials.gg INT018697
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2373652 | — | One source FDA |
| Wikidata | Q3645272 | stem bromelain | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.